People · Operator
Named in public records as an officer, director or promoter · active 2013–2019 · Biotechnology, Other Energy
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Decoy Biosystems, Inc. | — | Biotechnology | Series A | $6.4M | $232.0M | 2019 |
| Tauriga Sciences, Inc. | — | Other Energy | Seed | $2.6M | $25.3M | 2013 |
Stella M. Sung at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stella M. Sung on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael J Newman | 1 | 2 |
| BRIAN J. O'CALLAGHAN | 1 | 2 |
| Seth M. Shaw | 1 | 1 |
| David L. Wolitzky | 1 | 1 |
| Hoonmo J. Lee | 1 | 1 |
| Zahar Hakim | 1 | 1 |
| Treminio Antonio | 1 | 1 |
| Michael M. Wolff | 1 | 1 |
| L'Heureux Andre | 1 | 1 |
| Dawn M. Gibbons | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.